首页> 美国卫生研究院文献>PLoS Pathogens >Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

【2h】

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

机译：校正：基于CCR5 /整合酶抑制剂的联合治疗方案对未接受抗逆转录病毒治疗的HIV感染患者的粘膜免疫的影响：一项随机试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 PLoS Pathogens
作者
Sergio Serrano-Villar; Talia Sainz; Zhong-Min Ma; Netanya S. Utay; Tae Wook-Chun; Surinder Mann; Angela D. Kashuba; Basile Siewe; Anthony Albanese; Paolo Troia-Cancio; Elizabeth Sinclair; Anoma Somasunderam; Tammy Yotter; Steven G. Deeks; Alan Landay; Richard B. Pollard; Christopher J. Miller; Santiago Moreno; David M. Asmuth;
展开▼
作者单位

展开▼
年(卷),期 2017(13),5
年度 2017
页码 e1006368
总页数 3
原文格式 PDF
正文语种
中图分类微生物学;寄生动物、寄生虫学;医学寄生虫学;人体病毒学（致病病毒）;病毒（滤过性病毒）;
关键词

相似文献

外文文献
中文文献
专利

1. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Na?ve to Antiretroviral Therapy: A Pilot Randomized Trial [J] . Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, PLoS Pathogens . 2016,第1期

机译：联合CCR5 /基于整合酶抑制剂的方案对单纯接受抗逆转录病毒治疗的HIV感染患者的粘膜免疫的影响：一项随机试验
2. Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: A randomized controlled trial [J] . PatonN.I., GoodallR.L., DunnD.T., JAMA: the Journal of the American Medical Association . 2012,第4期

机译：羟氯喹对未接受抗逆转录病毒疗法的HIV感染患者的免疫活化和疾病进展的影响：一项随机对照试验
3. Ritonavir-boosted lopinavir as maintenance monotherapy in HIV-infected patients who achieved viral suppression during a second-line protease inhibitor-based regimen: A pilot randomized trial (bidi-mono) [J] . DepartmentofInternalMedicineBamrasnaraduraInfectiousDiseasesInstitute Journal of the International Association of Providers of AIDS Care. . 2014,第4期

机译：Ritonavir-Boosted Lopinavir作为艾滋病毒感染患者的维护单一疗法，在二线蛋白酶抑制剂的方案中实现病毒抑制：试验随机试验（Bidi-Mono）
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Results of a randomized, controlled trial to assess the toxicity and patient adherence with two short-course regimens for the prevention of tuberculosis, a two-month regimen of rifampin and pyrazinamide or a four-month regimen of rifampin only, in comparison with a control regimen of six-months-isoniazid. [D] . Geiter, Lawrence James. 1997

机译：与对照相比，采用两种短期疗程预防结核病，两个月利福平和吡嗪酰胺治疗或仅四个月利福平治疗，评估毒性和患者依从性的随机对照试验结果六个月异烟肼的治疗方案。
6. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial [O] . Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, 2016

机译：校正：基于CCR5 /整合酶抑制剂的联合治疗方案对未接受抗逆转录病毒治疗的HIV感染患者的粘膜免疫的影响：一项随机试验
7. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. [O] . Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, 2016

机译：校正：联合CCR5 /整合酶抑制剂为基础的方案对艾滋病毒感染患者的抗体免疫接种对抗逆转录病毒疗法的影响：一项试验性随机试验。

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

著录项

引文网络

相似文献

相关主题

期刊订阅